Clinical Trial Update: Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tolerability, pharmacokinetics, and the food effect of ZL-2102 in healthy male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• ZL-2102

Snippet

Sponsor: Zai Lab Pty. Ltd. | Conditions: Chronic Obstructive Pulmonary Disease, Asthma | Phase 1 | Status: UNKNOWN